Intriguingly, the Kaplan–Meier survival analysis showed that patients with gastric cancer who had increased ABCC2 expression had a significantly better overall survival rate (p = 0.0015 in 1044 total cases, Figure 1F). This evidence concerns the gene ABCC2 and gastric cancer.